Lineage Cell Therapeutics, Inc. announced that Brandi Roberts, Chief Financial Officer, provided notice of her resignation on January 15th, 2021, in order to accept a leadership position at another company. Ms. Roberts has committed to providing consulting services to Lineage to ensure an orderly and smooth transition to the Company’s new Chief Financial Officer. Mr. Brian Culley, Lineage’s Chief Executive Officer, will serve as Interim Chief Financial Officer until a new Chief Financial Officer has been appointed.